Harbor Investment Advisory, LLC Crispr Therapeutics Ag Transaction History
Harbor Investment Advisory, LLC
- $1.26 Billion
- Q4 2024
A detailed history of Harbor Investment Advisory, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Harbor Investment Advisory, LLC holds 4,455 shares of CRSP stock, worth $202,836. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,455
Previous 5,805
23.26%
Holding current value
$202,836
Previous $272,000
35.66%
% of portfolio
0.01%
Previous 0.02%
Shares
20 transactions
Others Institutions Holding CRSP
# of Institutions
488Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$409 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$398 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$174 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$126 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.75MShares$125 Million0.07% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.55B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....